<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02624843</url>
  </required_header>
  <id_info>
    <org_study_id>CTHP01</org_study_id>
    <nct_id>NCT02624843</nct_id>
  </id_info>
  <brief_title>Bioequivalence Study for Benzyl Alcohol Lotion 5%.</brief_title>
  <official_title>Bioequivalence Study for Benzyl Alcohol Lotion 5% (Hi-Tech Pharmacal Co. LTD) and Ulesfia (Benzyl Alcohol Lotion 5%) (Shionogi Inc.) in the Treatment of Head Lice and Their Ova.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Akorn, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>South Florida Family Health and Research Centers</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Axis Clinical Trials</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Akorn, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To establish the therapeutic equivalence and safety of a generic Benzyl Alcohol Lotion 5%&#xD;
      with Ulesfia Lotion 5% in eradication of head lice in the study subjects.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Infestation Successfully Eliminated by Active Treatment.</measure>
    <time_frame>Study Day 22 +/-2</time_frame>
    <description>Successful elimination of infestation by active treatment [Time frame: 22 + 2 days]. No evidence of active head lice infestation 22 days after enrollment.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">239</enrollment>
  <condition>Head Lice</condition>
  <arm_group>
    <arm_group_label>Benzyl Alcohol Lotion 5%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ulesfia (Benzyl Alcohol Lotion 5%)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vehicle Placebo Lotion 0%</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Benzyl Alcohol Lotion 5%</intervention_name>
    <description>White topical lotion</description>
    <arm_group_label>Benzyl Alcohol Lotion 5%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ulesfia (benzyl alcohol lotion) 5%</intervention_name>
    <description>White topical lotion</description>
    <arm_group_label>Ulesfia (Benzyl Alcohol Lotion 5%)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>White topical lotion</description>
    <arm_group_label>Vehicle Placebo Lotion 0%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy males or non-pregnant females aged 6 month or over with an upper age limit of&#xD;
             60 years.&#xD;
&#xD;
          -  Prospective participants upon examination are confirmed to have at least 3 live head&#xD;
             lice (defined as lice adults or nymphs) and at least 5 viable appearance louse eggs&#xD;
             (nits).&#xD;
&#xD;
          -  Prospective participants who give written informed consent or, if the participant is&#xD;
             under 17 years of age, whose parent/guardian gives written informed consent to&#xD;
             participate in the study.&#xD;
&#xD;
          -  Prospective participants who will be available for follow up visits over the 21 days&#xD;
             following first treatment.&#xD;
&#xD;
          -  Prospective female participants (including female caregivers) of childbearing&#xD;
             potential who are willing to provide a urine pregnancy test.&#xD;
&#xD;
          -  Prospective participants who agree not to shave their hair or use any other&#xD;
             pediculicide, nit combing, or louse treatment method during the course of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prospective participants with a known sensitivity to any of the ingredients in benzyl&#xD;
             alcohol lotion 5% (Hi-Tech Pharmacal Inc) or Ulesfia 5% (Shionogi Inc).&#xD;
&#xD;
          -  Prospective participants with a known history of irritation or sensitivity to&#xD;
             pediculicides or hair care products.&#xD;
&#xD;
          -  Prospective participants with a secondary bacterial infection of the scalp (eg.&#xD;
             impetigo/pyoderma) or have a secondary or long term scalp condition that could make it&#xD;
             difficult to evaluate the extent and severity of an infestation or that would present&#xD;
             a problem in the evaluation of response to therapy (e.g., psoriatic lesions of the&#xD;
             scalp, extensive seborrheic dermatitis).&#xD;
&#xD;
          -  Prospective participants who have been treated with other head lice products within 4&#xD;
             weeks prior to randomization.&#xD;
&#xD;
          -  Prospective participants who regularly shave their hair, have bleached their hair,&#xD;
             used a permanent color on their hair, or their hair has been permanently straightened&#xD;
             or waved within the previous 2 weeks.&#xD;
&#xD;
          -  Prospective participants who have been treated with Trimethoprim containing products&#xD;
             within the previous 4 weeks, or who are currently taking such a course.&#xD;
&#xD;
          -  Females who are pregnant, planning to become pregnant, during the course of the study&#xD;
             period, or are currently breast feeding mothers.&#xD;
&#xD;
          -  Females of childbearing potential who are unwilling to use an adequate method of&#xD;
             contraception from at least 4 weeks prior to the first application of treatment and&#xD;
             until 4 weeks after the last application of treatment, or who are unwilling to take a&#xD;
             urine pregnancy test.&#xD;
&#xD;
          -  Prospective participants who have participated in another clinical study or used an&#xD;
             investigational new drug within 1 month before entry into this study.&#xD;
&#xD;
          -  Participants who have already participated in this clinical study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elisabeth Rivera</last_name>
    <role>Principal Investigator</role>
    <affiliation>South Florida Family Health and Research Centers</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lydie Hazan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Axis Clinical Trials</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Clarke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Axis Clinical Trials</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lidia E Serrano</last_name>
    <role>Principal Investigator</role>
    <affiliation>South Florida Family Health and Research Centers</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nancy Pyram-Bernard, D.O.</last_name>
    <role>Principal Investigator</role>
    <affiliation>South Florida Family Health and Research Centers</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ian F Burgess, M.Phil.</last_name>
    <role>Study Director</role>
    <affiliation>Insect Research and Development LTD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Axis Clinical Trials</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Axis Clinical Trials</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Florida Family Health and Research Centers (Lice Source Services Inc)</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33186</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Florida Family Health and Research Centers (Lice Source Services Inc)</name>
      <address>
        <city>Plantation</city>
        <state>Florida</state>
        <zip>33313</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 25, 2015</study_first_submitted>
  <study_first_submitted_qc>December 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2015</study_first_posted>
  <results_first_submitted>August 18, 2020</results_first_submitted>
  <results_first_submitted_qc>August 18, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 3, 2020</results_first_posted>
  <last_update_submitted>January 11, 2021</last_update_submitted>
  <last_update_submitted_qc>January 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lice Infestations</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Benzyl Alcohol</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Benzyl Alcohol Lotion 5%</title>
          <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.&#xD;
Benzyl Alcohol Lotion 5%: White topical lotion</description>
        </group>
        <group group_id="P2">
          <title>Ulesfia (Benzyl Alcohol Lotion 5%)</title>
          <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.&#xD;
Ulesfia (benzyl alcohol lotion) 5%: White topical lotion</description>
        </group>
        <group group_id="P3">
          <title>Vehicle Placebo Lotion 0%</title>
          <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.&#xD;
Placebo: White topical lotion</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="107"/>
                <participants group_id="P2" count="108"/>
                <participants group_id="P3" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="70"/>
                <participants group_id="P2" count="72"/>
                <participants group_id="P3" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="36"/>
                <participants group_id="P3" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Benzyl Alcohol Lotion 5%</title>
          <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.&#xD;
Benzyl Alcohol Lotion 5%: White topical lotion</description>
        </group>
        <group group_id="B2">
          <title>Ulesfia (Benzyl Alcohol Lotion 5%)</title>
          <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.&#xD;
Ulesfia (benzyl alcohol lotion) 5%: White topical lotion</description>
        </group>
        <group group_id="B3">
          <title>Vehicle Placebo Lotion 0%</title>
          <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.&#xD;
Placebo: White topical lotion</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="107"/>
            <count group_id="B2" value="108"/>
            <count group_id="B3" value="24"/>
            <count group_id="B4" value="239"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="180"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="59"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="102"/>
                    <measurement group_id="B2" value="98"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="224"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="107"/>
                    <measurement group_id="B2" value="108"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="239"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Infestation Successfully Eliminated by Active Treatment.</title>
        <description>Successful elimination of infestation by active treatment [Time frame: 22 + 2 days]. No evidence of active head lice infestation 22 days after enrollment.</description>
        <time_frame>Study Day 22 +/-2</time_frame>
        <population>PP</population>
        <group_list>
          <group group_id="O1">
            <title>Benzyl Alcohol Lotion 5%</title>
            <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.&#xD;
Benzyl Alcohol Lotion 5%: White topical lotion</description>
          </group>
          <group group_id="O2">
            <title>Ulesfia (Benzyl Alcohol Lotion 5%)</title>
            <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.&#xD;
Ulesfia (benzyl alcohol lotion) 5%: White topical lotion</description>
          </group>
          <group group_id="O3">
            <title>Vehicle Placebo Lotion 0%</title>
            <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.&#xD;
Placebo: White topical lotion</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Infestation Successfully Eliminated by Active Treatment.</title>
          <description>Successful elimination of infestation by active treatment [Time frame: 22 + 2 days]. No evidence of active head lice infestation 22 days after enrollment.</description>
          <population>PP</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="72"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="57"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Benzyl Alcohol Lotion 5%</title>
          <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.&#xD;
Benzyl Alcohol Lotion 5%: White topical lotion</description>
        </group>
        <group group_id="E2">
          <title>Ulesfia (Benzyl Alcohol Lotion 5%)</title>
          <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.&#xD;
Ulesfia (benzyl alcohol lotion) 5%: White topical lotion</description>
        </group>
        <group group_id="E3">
          <title>Vehicle Placebo Lotion 0%</title>
          <description>Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.&#xD;
Placebo: White topical lotion</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="107"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="107"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="107"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>redness of eye</sub_title>
                <description>redness of eyes</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>fever</sub_title>
                <description>fever</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin, nervous system and general disorder</sub_title>
                <description>Hot paraesthesia on scalp</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Elisabeth Rivera</name_or_title>
      <organization>South Florida Family Health &amp; Research</organization>
      <phone>3053870051</phone>
      <email>elisabeth@sffhrc.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

